FDA/SEC Regulatory Coordination Talks Await New Securities Chairman
Executive Summary
FDA and the Securities & Exchange Commission are deferring discussions about ideas for closer cooperation pending the appointment of a new SEC chairman
You may also be interested in...
FDA/SEC Cooperation On Investor Communications To Be Headed By Taylor
FDA Associate Commissioner for Regulatory Affairs John Taylor will serve as the liaison with the Securities & Exchange Commission as FDA expands its role in regulating investor communications
FDA/SEC Cooperation On Investor Communications To Be Headed By Taylor
FDA Associate Commissioner for Regulatory Affairs John Taylor will serve as the liaison with the Securities & Exchange Commission as FDA expands its role in regulating investor communications
SEC’s Busy Week: Schering Notified Of Potential Suit; Waksal Expands Plea
SEC's crackdown on corporate accounting and investor communications is reaching deeper into the pharmaceutical sector